| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |